Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Dec 28;2015(12):CD005219.
doi: 10.1002/14651858.CD005219.pub3.

Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache

Michael H Bennett  1 , Christopher French, Alexander Schnabel, Jason Wasiak, Peter Kranke, Stephanie Weibel
Affiliations
Meta-Analysis

Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache

Michael H Bennett et al. Cochrane Database Syst Rev. .

Abstract

Background: Migraine and cluster headaches are severe and disabling. Migraine affects up to 18% of women, while cluster headaches are much less common (0.2% of the population). A number of acute and prophylactic therapies are available. Hyperbaric oxygen therapy (HBOT) is the therapeutic administration of 100% oxygen at environmental pressures greater than one atmosphere, while normobaric oxygen therapy (NBOT) is oxygen administered at one atmosphere. This is an updated version of the original Cochrane review published in Issue 3, 2008 under the title 'Normobaric and hyperbaric oxygen for migraine and cluster headache'.

Objectives: To examine the efficacy and safety of normobaric oxygen therapy (NBOT) and hyperbaric oxygen therapy (HBOT) in the treatment and prevention of migraine and cluster headache.

Search methods: We updated searches of the following databases up to 15 June 2015: CENTRAL (the Cochrane Library), MEDLINE, EMBASE, and CINAHL. For the original review we searched the following databases up to May 2008: CENTRAL, MEDLINE, EMBASE, CINAHL, DORCTIHM, and reference lists from relevant articles. We handsearched relevant journals and contacted researchers to identify trials.

Selection criteria: Randomised controlled trials comparing HBOT or NBOT with one another, other active therapies, placebo (sham) interventions, or no treatment in participants with migraine or cluster headache.

Data collection and analysis: Three review authors independently extracted data and assessed the quality of the evidence using the GRADE approach.

Main results: In this update, we included 11 trials with 209 participants. Five trials (103 participants) compared HBOT versus sham therapy for acute migraine, three trials compared NBOT to sham therapy or ergotamine tartrate for cluster headache (145 participants), two trials evaluated HBOT for cluster headache (29 participants), and one trial (56 participants) compared NBOT to sham for a mixed group of headache. The risk of bias varied considerably across these trials but in general trial quality was poor to moderate. One trial may not have been truly randomised and two included studies were reported as abstracts only. Seven trials did not indicate allocation concealment or randomisation method. Notably, 10 of the 11 trials used a sham comparator therapy and masked the outcome assessor to allocation.We pooled data from three trials, which suggested that HBOT was effective in relieving migraine headaches compared to sham therapy (risk ratio (RR) 6.21, 95% CI 2.41 to 16.00; 58 participants, three trials). The quality of evidence was low, having been downgraded for small crossover studies with incomplete reporting. There was no evidence that HBOT could prevent migraine episodes, reduce the incidence of nausea and vomiting, or reduce the requirement for rescue medication. There was no evidence that HBOT was effective for the termination of cluster headache (RR 11.38, 95% CI 0.77 to 167.85; P = 0.08) (one trial), but this trial had low power.NBOT was effective in terminating cluster headache compared to sham in a single small study (RR 7.88, 95% CI 1.13 to 54.66), but not superior to ergotamine administration in another small trial (RR 1.17, 95% CI 0.94 to 1.46; P = 0.16). A third trial reported a statistically significant difference in the proportion of attacks successfully treated with oxygen (117 of 150 attacks were successfully treated with NBOT (78%) versus 30 of 148 attacks treated with NBOT (20%)). The proportion of responders was consistent across these three trials, and suggested more than 75% of headaches were likely to respond to NBOT.No serious adverse events during HBOT or NBOT were reported.

Authors' conclusions: Since the last version of this review, two new included studies have provided additional information to change the conclusions. There was some evidence that HBOT was effective for the termination of acute migraine in an unselected population, and some evidence that NBOT was similarly effective in cluster headache. Given the cost and poor availability of HBOT, more research should be done on patients unresponsive to standard therapy. NBOT is cheap, safe, and easy to apply, so will probably continue to be used despite the limited evidence in this review.

PubMed Disclaimer

Conflict of interest statement

Michael Bennett has no relevant conflict of interest to declare. Christopher French has no relevant conflict of interest to declare. Alexander Schnabel has no relevant conflict of interest to declare. Jason Wasiak has no relevant conflict of interest to declare. Peter Kranke has no relevant conflict of interest to declare. Stephanie Weibel has no relevant conflict of interest to declare.

Figures

1
1
Study flow diagram.
2
2
'Risk of bias' graph: each 'Risk of bias' item presented as percentages across all included studies.
3
3
'Risk of bias' summary: review authors' judgements about each 'Risk of bias' item for each included study.
4
4
Forest plot of comparison: 1 HBOT versus control for acute migraine attack, outcome: 1.1 Substantial acute relief of headache.
1.1
1.1. Analysis
Comparison 1 HBOT versus control for acute migraine attack, Outcome 1 Substantial acute relief of headache.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Cohen 2009 {published data only}
    1. Cohen AS, Burns B, Goadsby PJ. High‐flow oxygen for treatment of cluster headache: a randomized trial. JAMA 2009;302(22):2451‐7. - PubMed
Di Sabato 1993 {published data only}
    1. Sabato F, Fusco BM, Pelaia P, Giacovazzo M. Hyperbaric oxygen therapy in cluster headache. Pain 1993;52(2):243‐5. - PubMed
Eftedal 2004 {published data only}
    1. Eftedal OS, Lydersen S, Helde G, White L, Brubakk AO, Stovner LJ. A randomised, double blind study of the prophylactic effect of hyperbaric oxygen therapy on migraine. Cephalalgia 2004;24(8):639‐44. - PubMed
Fife 1992 {published data only}
    1. Fife CE, Meyer JS, Berry JM, Sutton TE. Hyperbaric oxygen and acute migraine pain: preliminary results of a randomised blinded trial. Undersea Biomedical Research 1992;19:106‐7.
Fogan 1985 {published data only}
    1. Fogan L. Treatment of cluster headache. A double‐blind comparison of oxygen v air inhalation. Archives of Neurology 1985;42(4):362‐3. - PubMed
Hill 1992 {published data only}
    1. Hill RK. A blinded, crossover controlled study of the use of hyperbaric oxygen in the treatment of migraine headache. Undersea Biomedical Research 1992;19(S):106.
Kudrow 1981 {published data only}
    1. Kudrow L. Response of cluster headache attacks to oxygen inhalation. Headache 1981;21(1):1‐4. - PubMed
Myers 1995 {published data only}
    1. Myers DE, Myers RA. A preliminary report on hyperbaric oxygen in the relief of migraine headache. Headache 1995;35(4):197‐9. - PubMed
Nilsson Remahl 2002 {published data only}
    1. Nilsson Remahl AI, Ansjon R, Lind F, Waldenlind E. Hyperbaric oxygen treatment of active cluster headache: a double‐blind placebo‐controlled cross‐over study. Cephalalgia 2002;22(9):730‐9. - PubMed
Ozkurt 2012 {published data only}
    1. Ozkurt B, Cinar O, Cevik E, Acar AY, Arslan D, Eyi EY, et al. Efficacy of high‐flow oxygen therapy in all types of headache: A prospective, randomized, placebo‐controlled trial. Annals of Emergency Medicine. 2011; Vol. 1:S184. - PubMed
    1. Ozkurt B, Cinar O, Cevik E, Acar AY, Arslan D, Eyi EY, et al. Efficacy of high‐flow oxygen therapy in all types of headache: a prospective, randomized, placebo‐controlled trial. American Journal of Emergency Medicine 2012;30(9):1760‐4. - PubMed
Wilson 1998 {published data only}
    1. Wilson JR, Foresman GH, Gamber RG, Wright T. Hyperbaric oxygen in the treatment of migraine with aura. Headache 1998;38(2):112‐5. - PubMed

References to studies excluded from this review

Capobianco 2006 {published data only}
    1. Capobianco DJ, Dodick DW. Diagnosis and treatment of cluster headache. Seminars in Neurology 2006;26(2):242‐59. - PubMed
Chu 2010 {published data only}
    1. Chu J, Singh J. Relief from cluster headaches. American Journal of Nursing 2010;110(6):63.
Di Sabato 1996 {published data only}
    1. Sabato F, Giacovazzo M, Cristalli G, Rocco M, Fusco BM. Effect of hyperbaric oxygen on the immunoreactivity to substance P in the nasal mucosa of cluster headache patients. Headache 1996;36(4):221‐3. - PubMed
Di Sabato 1997 {published data only}
    1. Sabato F, Rocco M, Martelletti P, Giacovazzo M. Hyperbaric oxygen in chronic cluster headaches: influence on serotonergic pathways. Undersea & Hyperbaric Medicine 1997;24(2):117‐22. - PubMed
Drummond 1985 {published data only}
    1. Drummond PD, Anthony M. Extracranial vascular responses to sublingual nitroglycerine and oxygen inhalation in cluster headache patients. Headache 1985;25(2):70‐4. - PubMed
Ekbom 2004 {published data only}
    1. Ekbom K, Waldenlind E. Cluster headache: the history of the Cluster Club and a review of recent clinical research. Functional Neurology 2004;19(2):73‐81. - PubMed
Evers 1996 {published data only}
    1. Evers S, Husstedt IW. Alternatives in drug treatment of chronic paroxysmal hemicrania. Headache 1996;36(7):429‐32. - PubMed
Fife 1989 {published data only}
    1. Fife WP, Fife CE. Treatment of migraine with hyperbaric oxygen. Journal of Hyperbaric Medicine 1989;4:7‐15.
Fife 1991 {published data only}
    1. Fife CE, Meyer JS. Hyperbaric oxygen treatment of acute migraine headache. Headache Quarterly 1991;2(4):301‐6.
Francis 2010 {published data only}
    1. Francis GJ, Becker WJ, Pringsheim TM. Acute and preventive pharmacologic treatment of cluster headache. Neurology 2010;75(5):463‐73. - PubMed
Green 2003 {published data only}
    1. Green MW. The emergency management of headaches. Neurologist 2003;9(2):93‐8. - PubMed
Leone 2010 {published data only}
    1. Leone M, Franzini A, Proietti Cecchini A, Mea E, Broggi G, Bussone G. Management of chronic cluster headache. Current Treatment Options in Neurology 2011;13(1):56‐70. - PubMed
Mendizabal 1998 {published data only}
    1. Mendizabal JE, Umana E, Zweifler RM. Cluster headache: Horton's cephalalgia revisited. Southern Medical Journal 1998;91(7):606‐17. - PubMed
Nilsson Remahl 2003 {published data only}
    1. Nilsson Rehmal AI, Laudon Meyer E, Cordonnier C, Goadsby PJ. Placebo response in cluster headache trials: a review. Cephalalgia 2003;23(7):504‐10. [ISSN 0800‐1952] - PubMed
Nwosu 2005 {published data only}
    1. Nwosu IA, Khan AA. Hyperbaric oxygen therapy in primary headache: a research review. Biomedical Research 2005;16(3):143‐60.
Pascual 1995 {published data only}
    1. Pascual J, Peralta G, Sánchez U. Preventive effects of hyperbaric oxygen in cluster headache. Headache 1995;35(5):260‐1. - PubMed
Rozen 2004 {published data only}
    1. Rozen TD. High oxygen flow rates for cluster headache. Neurology 2004;63(3):593. - PubMed
Rozen 2005 {published data only}
    1. Rozen TD. Cluster headache: diagnosis and treatment. Current Pain & Headache Reports 2005;9(2):135‐40. [ISSN 1531‐3433] - PubMed

Additional references

AHC 1962
    1. Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA 1962;179(9):717‐8.
Alvarez 1939
    1. Alvarez WC. The new oxygen treatment for migraine. American Journal of Digestive Diseases 1939;6:728.
Bateman 1993
    1. Bateman DN. Sumatriptan. Lancet 1993;341(8839):221‐4. [MEDLINE: ] - PubMed
Bennett 2004
    1. Bennett M, Connor D. The Database of Randomised Controlled Trials in Hyperbaric Medicine (updated monthly). http://hboevidence.unsw.wikispaces.net/ (accessed 4th December 2015).
Burton 2002
    1. Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW. The economic burden of lost productivity due to migraine headache: a specific worksite analysis. Journal of Occupational and Environmental Medicine 2002;44(6):523‐9. [1076‐2752] - PubMed
Clark 2003
    1. Clark JM, Thom SR. Oxygen under pressure. In: Brubakk AO, Neuman TS editor(s). Bennett and Elliott's Physiology and Medicine of Diving. 5th Edition. London: Saunders, 2003:358‐418.
Curtin 2002
    1. Curtin F, Elbourne D, Altman DG. Meta‐analysis combining parallel and cross‐over clinical trials. Statistics in Medicine 2002;21(15):2145‐59. - PubMed
DerSimonian 1986
    1. DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88. - PubMed
Ekbom 1993
    1. Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. The Sumatriptan Cluster Headache Study Group. Acta Neurologica Scandinavica 1993;88(1):63‐9. [MEDLINE: ] - PubMed
Fife 1994
    1. Fife CE, Powell MG, Sutton TE, Meyer JS. Transcranial doppler evaluation of the middle cerebral artery from 1ATA to 3ATA PO2. Undersea and Hyperbaric Medicine 1994;21 Suppl:77. [10662936]
Gaul 2011
    1. Gaul C, Finken J, Biermann, J, Mostardt S, Diener HC, Müller O, et al. Treatment costs and indirect costs of cluster headache: A health economics analysis. Cephalalgia 2011;31(16):1664‐72. - PubMed
Goadsby 1997
    1. Goadsby PJ. Current concepts of the pathophysiology of migraine. Neurologic Clinics 1997;15(1):27‐42. [MEDLINE: ] - PubMed
Goadsby 2012
    1. Goadsby PJ. Pathophysiology of migraine. Annals of Indian Academy of Neurology 2012;15(Suppl 1):S15. - PMC - PubMed
Gomez‐Castillo 2005
    1. Gomez‐Castillo JD, Bennett MH. The cost of hyperbaric therapy at the Prince of Wales Hospital, Sydney. South Pacific Underwater Medicine Journal 2005;35(4):194‐8.
GRADEPro GDT 2015 [Computer program]
    1. McMaster University, 2015 (developed by Evidence Prime, Inc.). GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.), 2015.
Géraud 2004
    1. Géraud G, Lanteri‐Minet M, Lucas C, Valade D, French Society for the Study of Migraine Headache (SFEMC). French guidelines for the diagnosis and management of migraine in adults and children. Clinical Therapeutics 2004;26(8):1305‐18. [MEDLINE: ] - PubMed
Higgins 2009
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
Holland 2012
    1. Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence‐based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults. Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2012;78(17):1346‐53. - PMC - PubMed
Horton 1956
    1. Horton BT. Histaminic cephalgia: differential diagnosis and treatment. Proceedings of the Staff Meetings. Mayo Clinic 1956;31(11):325‐33. - PubMed
Hu 1999
    1. Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Archives of Internal Medicine 1999;159(8):813‐8. [MEDLINE: ] - PubMed
IHS 1988
    1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1‐96. - PubMed
IHS 2014
    1. Headache Classification Subcommittee of the International Headache Society. IHS Classification ICHD‐II. http://ihs‐classification.org/en/. International Headache Society, (accessed dd Month yyyy). [0022‐3050 0022‐3050]
Iversen 1990
    1. Iversen HK, Nielsen TH, Olesen J, Tfelt‐Hansen P. Arterial responses during migraine headache. Lancet 1990;336(8719):837‐9. - PubMed
Jain 2009
    1. Jain KK. Textbook of Hyperbaric Medicine. 5th Edition. Seattle: Hogrefe & Huber, 2009. [0‐88937‐203‐9]
Khan 2003
    1. Khan B, Evans AW, Easterbrook M. Refractive changes in patients undergoing hyperbaric oxygen therapy: a prospective study. Undersea & Hyperbaric Medicine 2003;24 Suppl:9.
Kindwall 2008
    1. Kindwall EP, Whelan HT. Hyperbaric Medicine Practice. 3rd Edition. Flagstaff, AZ: Best Publishing Company, 2008. [0‐941332‐78‐0]
Law 2013a
    1. Law S, Derry S, Moore RA. Naproxen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database of Systematic Reviews 2013, Issue 10. [DOI: 10.1002/14651858.CD009455.pub2] - DOI - PMC - PubMed
Law 2013b
    1. Law S, Derry S, Moore RA. Sumatriptan plus naproxen for acute migraine attacks in adults. Cochrane Database of Systematic Reviews 2013, Issue 10. [DOI: 10.1002/14651858.CD008541.pub2] - DOI - PubMed
Law 2013c
    1. Law S, Derry S, Moore RA. Triptans for acute cluster headache. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD008042.pub3] - DOI - PMC - PubMed
Linde 2013a
    1. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD010609] - DOI - PMC - PubMed
Linde 2013b
    1. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD010610] - DOI - PMC - PubMed
Mathew 2001
    1. Mathew NT. Pathophysiology, epidemiology, and impact of migraine. Clinical Cornerstone 2001;4(3):1‐17. - PubMed
Mathieu 2006
    1. Mathieu D. Handbook on Hyperbaric Medicine. 2nd Edition. Milan: Springer, 2006. [3‐540‐75016‐9]
May 2006
    1. May A, Leone M, Afra J, Linde M, Sándor PS, Evers S, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal‐autonomic cephalalgias. European Journal of Neurology 2006;13(10):1066‐77. - PubMed
Munakata 2009
    1. Munakata J, Hazard E, Serrano D, Klingman D, Rupnow MF, Tierce J, et al. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study. Headache: The Journal of Headache and Face Pain 2009;49(4):498‐508. - PubMed
Nesbitt 2012
    1. Nesbitt AD, Goadsby PJ. Cluster headache. BMJ 2012;344:e2407. - PubMed
Osterhaus 1992
    1. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics 1992;2(1):67‐76. - PubMed
Piane 2007
    1. Piane M, Lulli P, Farinelli I, Simeoni S, Filippis S, Patacchioli FR, et al. Genetics of migraine and pharmacogenomics: some considerations. The Journal of Headache and Pain 2007;8(6):334‐9. - PMC - PubMed
RevMan 2014 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Russell 2004
    1. Russell MB. Epidemiology and genetics of cluster headache. Lancet Neurology 2004;3(5):279‐83. - PubMed
Slotman 1998
    1. Slotman GJ. Hyperbaric oxygen in systemic inflammation ... HBO is not just a movie channel anymore. Critical Care Medicine 1998;26(12):1932‐3. [MEDLINE: ] - PubMed
Smitherman 2013
    1. Smitherman TA, Burch R, Sheikh H, Loder E. The Prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache 2013;53(3):427‐36. - PubMed
Stokes 2011
    1. Stokes M, Becker WJ, Lipton RB, Sullivan SD, Wilcox TK, Wells L, et al. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache: The Journal of Head and Face Pain 2011;51(7):1058‐77. - PubMed
Sümen 2001
    1. Sümen G, Cimşit M, Eroglu L. Hyperbaric oxygen treatment reduces carrageenan‐induced acute inflammation in rats. European Journal of Pharmacology 2001;431(2):265‐8. [MEDLINE: ] - PubMed
Taylor 2011
    1. Taylor FR. Nutraceuticals and headache: the biological basis. Headache: The Journal of Head and Face Pain 2011;51(3):484‐501. - PubMed
Vos 2013
    1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 2013;380(9859):2163‐96. - PMC - PubMed
Weiss 1989
    1. Weiss LD, Ramasastry SS, Eidelman BH. Treatment of a cluster headache patient in a hyperbaric chamber. Headache 1989;29(2):109‐10. [MEDLINE: ] - PubMed
Wider 2015
    1. Wider B, Pittler MH, Ernst E. Feverfew for preventing migraine. Cochrane Database of Systematic Reviews 2015, Issue 4. [DOI: 10.1002/14651858.CD002286] - DOI - PMC - PubMed
Yusa 1987
    1. Yusa T, Beckman JS, Crapo JD, Freeman BA. Hyperoxia increases H2O2 production by brain in vivo. Journal of Applied Physiology 1987;63(1):353‐8. - PubMed

References to other published versions of this review

Bennett 2005
    1. Bennett MH, French C, Kranke P, Schnabel A, Wasiak J. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache. Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD005219] - DOI - PMC - PubMed
Bennett 2008
    1. Bennett MH, French C, Schnabel A, Wasiak J, Kranke P. Normobaric and hyperbaric oxygen therapy for migraine and cluster headache. Cochrane Database of Systematic Reviews 2008, Issue 7. [DOI: 10.1002/14651858.CD005219.pub2] - DOI - PubMed

MeSH terms